NCT07849699

Brief Summary

The overall objective of this study is to test the effectiveness and implementability of stepped OFLN in a noninferiority randomized controlled trial (RCT) using a hybrid type 1 (effectiveness-implementation) design.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
294

participants targeted

Target at P75+ for not_applicable

Timeline
53mo left

Started Feb 2027

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 24, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 30, 2026

Completed
4 months until next milestone

Study Start

First participant enrolled

February 1, 2027

Expected
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2030

6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2031

Last Updated

September 30, 2026

Status Verified

September 1, 2026

Enrollment Period

3.8 years

First QC Date

September 24, 2026

Last Update Submit

September 24, 2026

Conditions

Keywords

Financial toxicityAdolescent and Young AdultOncology financial and legal navigationHardship

Outcome Measures

Primary Outcomes (2)

  • Change in Financial Toxicity: Psychological Response

    Financial toxicity (psychological response) will be measured using the 11-item Comprehensive Score for Financial Toxicity (COST) that measures emotional aspects of financial hardship (financial toxicity) among cancer patients. Each item is scored on a 5-point ordinal scale ranging from 0='Not at all' to 4='Very much. Lower values indicate greater financial toxicity.

    From baseline to 12-, 30- (primary), and 48-weeks; and also measured every 6 weeks as screener

  • Implementation Outcomes

    Intervention acceptability, appropriateness and feasibility will be measured using the Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM) and Feasibility of Intervention Measure (FIM) with 12 items total, 3 subscales. Higher scores indicate greater intervention acceptability, appropriateness and feasibility.

    Measured at 30-weeks and 48-weeks

Secondary Outcomes (8)

  • Change in Financial Toxicity: Material Burden

    Baseline to 12-, 30-, and 48-weeks

  • Change in Financial Toxicity: Coping Burden

    Baseline to 12-, 30- and 48-weeks

  • Change in Cost-related Health Literacy

    From baseline to 12-, 30-, and 48-weeks

  • Change in Participant Quality of Life

    Baseline to 12-, 30-, and 48-weeks.

  • Change in Participant Quality of Life (Anxiety)

    Baseline to 12-, 30- and 48-weeks

  • +3 more secondary outcomes

Study Arms (2)

OFLN Stepped Arm

EXPERIMENTAL

Once randomized to the stepped OFLN intervention arm, patients with a lower financial toxicity at baseline will be assigned to the low-intensity OFLN and patients with high financial toxicity will be assigned to the high-intensity OFLN.

Other: OFLN Stepped: Low IntensityOther: OFLN Stepped: High-Intensity

OFLN Standard

ACTIVE COMPARATOR

Patients randomized to the standard OFLN arm will receive standard navigation services which includes access to a virtual, navigator-led program.

Other: OFLN Standard

Interventions

Patients' baseline needs will be reviewed by Triage Cancer navigators who will build and personalize their self-managed navigation program and mail introductory packets and resource materials to patient. Pt will receive an email link to access their personalized program. The program will include a customized package of Triage Cancer's educational resources (e.g., webinars, quick guides, interactive tools. Patients will have roughly 4 weeks to complete their program, lasting \~4 hours, and any self-directed activities. Completion verification and engagement tracking questions are included in weekly check-in surveys to monitor progress. Following each 6-week screening, participants whose FT scores remain stable or improve will continue to receive an email with resources customized to newly identified needs until 30 weeks. Patients whose FT worsens and who meet criteria for stepping up following screenings (within the 30-week period) will be stepped into the high intensity arm.

OFLN Stepped Arm

Once randomized in the standard OFLN arm, patients will be contacted by Triage Cancer navigators via email to schedule an initial phone consultation to review needs and collect pertinent information on insurance and employment, income, billing and other details to help connect patients with appropriate resources. Triage Cancer navigators will meet with all enrolled patients for a minimum of 6 phone/videocall appointments starting with an initial consultation at baseline and follow-up appointments every 6 weeks following FT screenings, and as needed. All patient will receive navigation services for 30 weeks. Additional intensive legal services (i.e., legal counseling or representation) that require a jurisdiction-specific licensed lawyers will be provided by the research team's supervising attorney.

OFLN Standard

Once enrolled in the high-intensity OFLN arm, patients will be contacted by Triage Cancer navigators via email to schedule an initial phone consultation to review needs and collect pertinent information on insurance and employment, income, billing and other details to help connect patients with appropriate resources. Triage Cancer navigators will meet with all enrolled patients for a minimum of 6 phone/videocall appointments starting with an initial consultation at baseline and follow-up appointments every 6 weeks following FT screenings, and as needed. All patient will receive navigation services for 30 weeks. Additional intensive legal services (i.e., legal counseling or representation) that require a jurisdiction-specific licensed lawyers will be provided by the research team's supervising attorney.

OFLN Stepped Arm

Eligibility Criteria

Age18 Years - 39 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Newly diagnosed with cancer within the past 12 months
  • Able to read and speak English or Spanish
  • Actively receiving healthcare at the University of Louisville

You may not qualify if:

  • Cognitive impairments that would interfere with participation
  • Unable to read and speak English or Spanish

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Louisville-Brown Cancer Center

Louisville, Kentucky, 40202, United States

Location

MeSH Terms

Conditions

Financial Stress

Condition Hierarchy (Ancestors)

Stress, PsychologicalBehavioral SymptomsBehavior

Study Officials

  • Jean Edward, PhD, RN, FAAN

    University of Louisville-Brown Cancer Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jean Edward, PhD, RN, FAAN

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: The OFLN intervention will used a stepped-intensity model to provide low- and high-intensity navigation services.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Associate Dean for Faculty Development and Mentoring School of Nursing; Deputy Director of Nursing Research, Brown Cancer Center

Study Record Dates

First Submitted

September 24, 2026

First Posted

September 30, 2026

Study Start (Estimated)

February 1, 2027

Primary Completion (Estimated)

December 1, 2030

Study Completion (Estimated)

June 1, 2031

Last Updated

September 30, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

Locations